Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Soluble receptor of advanced glycation end products (sRAGE) indicates response to chemotherapy in pancreatic cancer patients.

Wittwer C, Boeck S, Heinemann V, Haas M, Stieber P, Nagel D, Holdenrieder S.

Int J Clin Pharmacol Ther. 2013 Jan;51(1):67-9. No abstract available.

2.

Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.

Wittwer C, Boeck S, Heinemann V, Haas M, Stieber P, Nagel D, Holdenrieder S.

Int J Cancer. 2013 Dec 1;133(11):2619-30. doi: 10.1002/ijc.28294. Epub 2013 Aug 9.

3.

Personal experience in advanced pancreatic cancer: retrospective analysis on the use of 5-fluorouracil or gemcitabine.

Martinelli B, Pigni A, Fagnoni E, Chini C, Vallini I, Pinotti G.

Dig Liver Dis. 2001 Aug-Sep;33(6):503. No abstract available.

PMID:
11572580
4.

Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer.

Halm U, Schumann T, Schiefke I, Witzigmann H, Mössner J, Keim V.

Br J Cancer. 2000 Mar;82(5):1013-6.

5.

Gemcitabine doublets in advanced pancreatic cancer: should we move on?

Rocha Lima CM, Flores AM.

J Clin Oncol. 2006 Jan 20;24(3):327-9. Epub 2005 Dec 12. No abstract available.

PMID:
16344312
6.

Serum tumor markers for pancreatic cancer: the dawn of new era?

Okusaka T, Yamada T, Maekawa M.

JOP. 2006 Jul 10;7(4):332-6. No abstract available.

7.
8.

Objective outcome measures of quality of life.

Burris HA 3rd.

Oncology (Williston Park). 1996 Nov;10(11 Suppl):131-5.

PMID:
8953600
9.

Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.

Boeck S, Wilkowski R, Bruns CJ, Issels RD, Schulz C, Moosmann N, Laessig D, Haas M, Golf A, Heinemann V.

Oncology. 2007;73(3-4):221-7. doi: 10.1159/000127413. Epub 2008 Apr 17.

PMID:
18424886
10.
11.

Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

Oztop I, Yilmaz U, Yavuzsen T, Yaren A, Tarhan O, Sagol O, Coker A, Alakavuklar M.

Chemotherapy. 2004 Jun;50(3):127-32.

PMID:
15282439
12.

Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.

Park JK, Ryu JK, Lee JK, Yoon WJ, Lee SH, Kim YT, Yoon YB.

Pancreas. 2006 Nov;33(4):397-402.

PMID:
17079946
13.

Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.

Hartel M, di Mola FF, Selvaggi F, Mascetta G, Wente MN, Felix K, Giese NA, Hinz U, Di Sebastiano P, Büchler MW, Friess H.

Gut. 2006 Apr;55(4):519-28. Epub 2005 Sep 20.

14.

[Prognostic significance of CA19-9 levels in patients with pancreatic cancer].

Shiozawa S, Tsuchiya A, Kim DH, Ogawa K.

Nihon Rinsho. 2006 Jan;64 Suppl 1:297-300. Review. Japanese. No abstract available.

PMID:
16457270
15.

Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy.

Ren C, Han C, Zhang J, He P, Wang D, Wang B, Zhao P, Zhao X.

Cancer Biol Ther. 2011 Oct 15;12(8):700-6. doi: 10.4161/cbt.12.8.15960. Epub 2011 Oct 15.

PMID:
21811100
16.

What options are available for refractory pancreatic cancer?

Choi M, Kim R, Saif MW.

JOP. 2012 Mar 10;13(2):163-5. Review.

17.

Pancreatic cancer.

[No authors listed]

Clin Evid. 2003 Jun;(9):528-33. Review. No abstract available. Update in: Clin Evid. 2004 Jun;(11):626-32.

PMID:
12967377
18.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.

Ward S, Morris E, Bansback N, Calvert N, Crellin A, Forman D, Larvin M, Radstone D.

Health Technol Assess. 2001;5(24):1-70. Review. No abstract available.

19.

[Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy].

An X, Li YH, Lin XB, Wang FH, Feng F, Xu RH, Jiang WQ, He YJ.

Ai Zheng. 2009 Mar;28(3):286-91.

PMID:
19619444
20.

[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

Gong JF, Zhang XD, Li J, Di LJ, Jin ML, Shen L.

Ai Zheng. 2007 Aug;26(8):890-4. Chinese.

PMID:
17697554

Supplemental Content

Support Center